Global and United States Healthcare-Acquired Infection Market Report & Forecast 2023-2028

Report ID: 1830720 | Published Date: Oct 2024 | No. of Page: 86 | Base Year: 2023 | Rating: 3.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Healthcare-Acquired Infection Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Healthcare-Acquired Infection Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Healthcare-Acquired Infection Market Size for the Year 2017-2028
        1.2.2 Global Healthcare-Acquired Infection Market Size for the Year 2017-2028
    1.3 Healthcare-Acquired Infection Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Healthcare-Acquired Infection in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Healthcare-Acquired Infection Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Healthcare-Acquired Infection Market Dynamics
        1.4.1 Healthcare-Acquired Infection Industry Trends
        1.4.2 Healthcare-Acquired Infection Market Drivers
        1.4.3 Healthcare-Acquired Infection Market Challenges
        1.4.4 Healthcare-Acquired Infection Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Healthcare-Acquired Infection by Type
    2.1 Healthcare-Acquired Infection Market Segment by Type
        2.1.1 Pharmaceutical Treatment
        2.1.2 Environment Treatment
        2.1.3 Medical Devices Management
    2.2 Global Healthcare-Acquired Infection Market Size by Type (2017, 2022 & 2028)
    2.3 Global Healthcare-Acquired Infection Market Size by Type (2017-2028)
    2.4 United States Healthcare-Acquired Infection Market Size by Type (2017, 2022 & 2028)
    2.5 United States Healthcare-Acquired Infection Market Size by Type (2017-2028)
3 Healthcare-Acquired Infection by Application
    3.1 Healthcare-Acquired Infection Market Segment by Application
        3.1.1 Hospital
        3.1.2 Clinics
        3.1.3 Ambulatory Surgery Centers
        3.1.4 Others
    3.2 Global Healthcare-Acquired Infection Market Size by Application (2017, 2022 & 2028)
    3.3 Global Healthcare-Acquired Infection Market Size by Application (2017-2028)
    3.4 United States Healthcare-Acquired Infection Market Size by Application (2017, 2022 & 2028)
    3.5 United States Healthcare-Acquired Infection Market Size by Application (2017-2028)
4 Global Healthcare-Acquired Infection Competitor Landscape by Company
    4.1 Global Healthcare-Acquired Infection Market Size by Company
        4.1.1 Top Global Healthcare-Acquired Infection Companies Ranked by Revenue (2021)
        4.1.2 Global Healthcare-Acquired Infection Revenue by Player (2017-2022)
    4.2 Global Healthcare-Acquired Infection Concentration Ratio (CR)
        4.2.1 Healthcare-Acquired Infection Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Healthcare-Acquired Infection in 2021
        4.2.3 Global Healthcare-Acquired Infection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Healthcare-Acquired Infection Headquarters, Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Healthcare-Acquired Infection Headquarters and Area Served
        4.3.2 Global Healthcare-Acquired Infection Companies Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Healthcare-Acquired Infection Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Healthcare-Acquired Infection Market Size by Company
        4.5.1 Top Healthcare-Acquired Infection Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Healthcare-Acquired Infection Revenue by Players (2020, 2021 & 2022)
5 Global Healthcare-Acquired Infection Market Size by Region
    5.1 Global Healthcare-Acquired Infection Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Healthcare-Acquired Infection Market Size by Region (2017-2028)
        5.2.1 Global Healthcare-Acquired Infection Market Size by Region: 2017-2022
        5.2.2 Global Healthcare-Acquired Infection Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Healthcare-Acquired Infection Market Size YoY Growth 2017-2028
        6.1.2 North America Healthcare-Acquired Infection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Healthcare-Acquired Infection Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Healthcare-Acquired Infection Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Healthcare-Acquired Infection Market Size YoY Growth 2017-2028
        6.3.2 Europe Healthcare-Acquired Infection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Healthcare-Acquired Infection Market Size YoY Growth 2017-2028
        6.4.2 Latin America Healthcare-Acquired Infection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Healthcare-Acquired Infection Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Healthcare-Acquired Infection Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Pfizer
        7.1.1 Pfizer Company Details
        7.1.2 Pfizer Business Overview
        7.1.3 Pfizer Healthcare-Acquired Infection Introduction
        7.1.4 Pfizer Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.1.5 Pfizer Recent Development
    7.2 Novartis
        7.2.1 Novartis Company Details
        7.2.2 Novartis Business Overview
        7.2.3 Novartis Healthcare-Acquired Infection Introduction
        7.2.4 Novartis Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.2.5 Novartis Recent Development
    7.3 Roche
        7.3.1 Roche Company Details
        7.3.2 Roche Business Overview
        7.3.3 Roche Healthcare-Acquired Infection Introduction
        7.3.4 Roche Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.3.5 Roche Recent Development
    7.4 Sanofi
        7.4.1 Sanofi Company Details
        7.4.2 Sanofi Business Overview
        7.4.3 Sanofi Healthcare-Acquired Infection Introduction
        7.4.4 Sanofi Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.4.5 Sanofi Recent Development
    7.5 Abbott
        7.5.1 Abbott Company Details
        7.5.2 Abbott Business Overview
        7.5.3 Abbott Healthcare-Acquired Infection Introduction
        7.5.4 Abbott Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.5.5 Abbott Recent Development
    7.6 BD
        7.6.1 BD Company Details
        7.6.2 BD Business Overview
        7.6.3 BD Healthcare-Acquired Infection Introduction
        7.6.4 BD Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.6.5 BD Recent Development
    7.7 Hologic
        7.7.1 Hologic Company Details
        7.7.2 Hologic Business Overview
        7.7.3 Hologic Healthcare-Acquired Infection Introduction
        7.7.4 Hologic Revenue in Healthcare-Acquired Infection Business (2017-2022)
        7.7.5 Hologic Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Healthcare-Acquired Infection Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Healthcare-Acquired Infection Market Trends
    Table 3. Healthcare-Acquired Infection Market Drivers
    Table 4. Healthcare-Acquired Infection Market Challenges
    Table 5. Healthcare-Acquired Infection Market Restraints
    Table 6. Global Healthcare-Acquired Infection Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Healthcare-Acquired Infection Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Healthcare-Acquired Infection Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Healthcare-Acquired Infection Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Healthcare-Acquired Infection Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Healthcare-Acquired Infection Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Healthcare-Acquired Infection Revenue Share by Player, 2017-2022
    Table 13. Global Healthcare-Acquired Infection Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Healthcare-Acquired Infection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Healthcare-Acquired Infection as of 2021)
    Table 15. Top Players of Healthcare-Acquired Infection in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Healthcare-Acquired Infection Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Healthcare-Acquired Infection Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Healthcare-Acquired Infection Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Healthcare-Acquired Infection Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Healthcare-Acquired Infection Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Healthcare-Acquired Infection Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Healthcare-Acquired Infection Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Healthcare-Acquired Infection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Healthcare-Acquired Infection Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Healthcare-Acquired Infection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Healthcare-Acquired Infection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Healthcare-Acquired Infection Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Pfizer Company Details
    Table 31. Pfizer Business Overview
    Table 32. Pfizer Healthcare-Acquired Infection Product
    Table 33. Pfizer Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 34. Pfizer Recent Development
    Table 35. Novartis Company Details
    Table 36. Novartis Business Overview
    Table 37. Novartis Healthcare-Acquired Infection Product
    Table 38. Novartis Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 39. Novartis Recent Development
    Table 40. Roche Company Details
    Table 41. Roche Business Overview
    Table 42. Roche Healthcare-Acquired Infection Product
    Table 43. Roche Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 44. Roche Recent Development
    Table 45. Sanofi Company Details
    Table 46. Sanofi Business Overview
    Table 47. Sanofi Healthcare-Acquired Infection Product
    Table 48. Sanofi Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 49. Sanofi Recent Development
    Table 50. Abbott Company Details
    Table 51. Abbott Business Overview
    Table 52. Abbott Healthcare-Acquired Infection Product
    Table 53. Abbott Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 54. Abbott Recent Development
    Table 55. BD Company Details
    Table 56. BD Business Overview
    Table 57. BD Healthcare-Acquired Infection Product
    Table 58. BD Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 59. BD Recent Development
    Table 60. Hologic Company Details
    Table 61. Hologic Business Overview
    Table 62. Hologic Healthcare-Acquired Infection Product
    Table 63. Hologic Revenue in Healthcare-Acquired Infection Business (2017-2022) & (US$ Million)
    Table 64. Hologic Recent Development
    Table 65. Research Programs/Design for This Report
    Table 66. Key Data Information from Secondary Sources
    Table 67. Key Data Information from Primary Sources
List of Figures
    Figure 1. Healthcare-Acquired Infection Product Picture
    Figure 2. Global Healthcare-Acquired Infection Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Healthcare-Acquired Infection Market Size 2017-2028 (US$ Million)
    Figure 4. United States Healthcare-Acquired Infection Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Healthcare-Acquired Infection Market Size 2017-2028 (US$ Million)
    Figure 6. United States Healthcare-Acquired Infection Market Share in Global 2017-2028
    Figure 7. Healthcare-Acquired Infection Report Years Considered
    Figure 8. Product Picture of Pharmaceutical Treatment
    Figure 9. Product Picture of Environment Treatment
    Figure 10. Product Picture of Medical Devices Management
    Figure 11. Global Healthcare-Acquired Infection Market Share by Type in 2022 & 2028
    Figure 12. Global Healthcare-Acquired Infection Market Size by Type (2017-2028) & (US$ Million)
    Figure 13. Global Healthcare-Acquired Infection Market Share by Type (2017-2028)
    Figure 14. United States Healthcare-Acquired Infection Market Share by Type in 2022 & 2028
    Figure 15. United States Healthcare-Acquired Infection Market Size by Type (2017-2028) & (US$ Million)
    Figure 16. United States Healthcare-Acquired Infection Market Share by Type (2017-2028)
    Figure 17. Product Picture of Hospital
    Figure 18. Product Picture of Clinics
    Figure 19. Product Picture of Ambulatory Surgery Centers
    Figure 20. Product Picture of Others
    Figure 21. Global Healthcare-Acquired Infection Market Share by Application in 2022 & 2028
    Figure 22. Global Healthcare-Acquired Infection Market Size by Application (2017-2028) & (US$ Million)
    Figure 23. Global Healthcare-Acquired Infection Market Share by Application (2017-2028)
    Figure 24. United States Healthcare-Acquired Infection Market Share by Application in 2022 & 2028
    Figure 25. United States Healthcare-Acquired Infection Market Size by Application (2017-2028) & (US$ Million)
    Figure 26. United States Healthcare-Acquired Infection Market Share by Application (2017-2028)
    Figure 27. North America Healthcare-Acquired Infection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 28. U.S. Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 29. Canada Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Europe Healthcare-Acquired Infection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 31. Germany Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. France Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. U.K. Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Italy Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Russia Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Asia-Pacific Healthcare-Acquired Infection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 37. China Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. Japan Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. South Korea Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. India Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Australia Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Taiwan Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Indonesia Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Thailand Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Malaysia Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Philippines Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Latin America Healthcare-Acquired Infection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 48. Mexico Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Brazil Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Argentina Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Middle East & Africa Healthcare-Acquired Infection Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 52. Turkey Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. U.A.E Healthcare-Acquired Infection Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. Pfizer Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 56. Novartis Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 58. Sanofi Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 59. Abbott Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 60. BD Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 61. Hologic Revenue Growth Rate in Healthcare-Acquired Infection Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Pfizer
Novartis
Roche
Sanofi
Abbott
BD
Hologic
Frequently Asked Questions
Healthcare-Acquired Infection report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Healthcare-Acquired Infection report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Healthcare-Acquired Infection report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports